PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
70 hedge funds and large institutions have $251M invested in Progenics Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
Holders
70
Holding in Top 10
–
Calls
$484K
Puts
$1.33M
Top Buyers
1 | +$3.33M | |
2 | +$2.78M | |
3 | +$661K | |
4 |
JG
Jefferies Group
New York
|
+$644K |
5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$613K |
Top Sellers
1 | -$13.8M | |
2 | -$3.84M | |
3 | -$2.2M | |
4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.7M |
5 |
Renaissance Technologies
New York
|
-$1.41M |